anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
The invention belongs to the technical field of novel biological materials, and discloses application of hyaluronic acid in improving polysaccharide-polypeptide composite hydrogel performance. Based on the self-assembly characteristic of the polypeptide, the polysaccharide-polypeptide composite hydrogel of Hyaluronic Acid (HA) with different concentrations is prepared. Verified that: compared with single polypeptide hydrogel without added HA, the HA reduces the mechanical property of the composite gel, but can still delay the degradation rate of the composite hydrogel and improve the stability of the composite hydrogel. The HA can also improve the loading capacity of the composite hydrogel on quercetin and dihydroflavonoid glycoside, and HAs a delay effect on the in-vitro release of the quercetin and the dihydroflavonoid glycoside, so that the sustained release of the active substances is facilitated. In addition, the addition of HA does not affect the secondary structure and the micro-nano structure of the composite hydrogel, and can also improve the strength of non-covalent interaction force between molecules and the stability of the composite hydrogel. The invention detects the influence of HA on the performance of the composite hydrogel and provides theoretical basis for the research of the hydrophobic drug delivery carrier.
PURPOSE:To prepare a cosmetic having high safety and excellent emulsifiability, moisture-retainability, and feeling to the skin, by compounding a vegetable protein or a partially hydrolyzed vegetable protein represented by the alcohol- denaturated soybean protein. CONSTITUTION:The objective cosmetic is prepared by compounding a vegetable protein or a partially hydrolyzed vegetable protein obtained by the hydrolysis of a vegetable protein with a protease (e.g. pepsin, ''Bioprase '', etc.) in an amount of 0.05-10wt%. Although soybean protein, wheat protein, etc. may be used as the vegetable protein; however, it is preferable to use soybean protein, especially the alcohol-denaturated soybean protein obtained by washing the soybean protein with 50-80wt% hydrous alcohol. The cosmetic thus obtained has excellent emulsified state and emulsion stability, and gives low stimulation, excellent feeling and emolient property to the skin. It protects the hair, and imparts the hair with gloss and softness.
The aim of this research is to gain a better understanding of factors that relate to the increased health and effective functioning of older adults. Specifically, efficiency of psychomotor performance declines with advancing age leading to profound effects on older adults' quality of life. For this reason, researchers have focused on the influence that individual lifestyle habits have on the aging process. One lifestyle choice that has been found to positively contribute to the efficiency of older adults' psychomotor performance is cardiovascular exercise. This relationship appears to be especially significant when older adults are challenged with more complex or effortful tasks. Previous research has led investigators to believe that aging has a specific, rather than generalized, impact on cognitive functioning. Also, prolonged participation in cardiovascular exercise has been found to maintain the cognitive functioning critical for healthy aging.

Therefore, the purpose of this research is to examine the role of an organized 6-month cardiovascular exercise intervention trial on electrocortical (event-related brain potential) and behavioral measures (reaction time) of executive control. In addition, a non-cardiovascular exercise control group that participates in a 6-month stretching and toning program will be used for comparison. Participants will be measured before and after exercise training during engagement in several tasks designed to elicit different executive functions (e.g., discrimination, task switching, inhibition). Each task also contains a non-executive condition that will be used for comparison to examine the specificity of exercise participation of cognitive functioning. A secondary aim of this project is to determine the effects of an acute bout of exercise on cognitive functioning. Both groups will participate in several bouts of exercise followed by immediate measurement on the tasks outlined above to determine whether acute exercise has beneficial effects on executive processes. The significance of this research may include the increased understanding of factors related to the amelioration of age-related decrements in central nervous system functioning and recommendations for the maintenance of cognitive health during the later stages of life.
Aims 1 and 2 are retrospective and will be conducted with the same dataset, just at two different time points (at diagnosis of CTEPH and after PTE surgery). For simplicity, aims 1 and 2 will be combined into one section throughout the protocol.
PROBLEM TO BE SOLVED: To obtain the cosmetic composition having a persistent physiological effect, high in a skin-beautifying effect and useful for skin cases, hair cares and bathing agents by combining specific compounds. SOLUTION: This cosmetic composition contains sodium chloride and glycolic acid and/or glycolic acid salt (alkali metal salt, alkaline earth metal salt, ammonium salt or amine salt) in a weight ratio of 1:100 to 100:1. The cosmetic composition may contain a composition comprising the hydrolysis reaction solution of monochloroacetic acid with an alkali metal base (sodium hydroxide, etc.), in an aqueous medium or a composition comprising the mixture of the reaction solution with a mineral acid (hydrochloric acid, etc.), or an alkali metal base (sodium hydroxide, etc.), an alkaline earth metal base (calcium oxide, etc.), ammonia or an amine (methyl amine, etc.). The hydrolysis reaction is carried out in a charged monochloroacetic acid concentration of 30-60wt.% and in an alkali metal base concentration of 0.9-2.5 times that of the monochloroacetic acid at a temperature of 70-130 deg.C.
An 88-year-old woman with atrial fibrillation was admitted to our hospital due to the right hemiplegia and aphasia. MRA shows the left middle cerebral artery M2 occlusion. After intravenous rt-PA, her symptoms improved. She was diagnosed with cardioembolic stroke, and was treated with direct oral anticoagulation therapy. However, she had repeated stereotypical transient right hemiparesis a week after index stroke. Her symptoms were considered capsular warning syndrome (CWS). After cilostazol was administered, no further transient neurological deteriorations occurred. CWS can coexist with acute cardioembolic stroke, and cilostazol was effective.
METADATE ER Tablets (methylphenidate hydrochloride extended-release tablets, USP) are a mild central nervous system (CNS) stimulant. METADATE ER is available as 20 mg extended-release tablets for oral administration.

Methylphenidate hydrochloride is methyl α-phenyl-2-piperidineacetate hydrochloride, and its structural formula is:

Methylphenidate hydrochloride is a white, odorless, fine crystalline powder. Its solutions are acid to litmus. It is freely soluble in water and in methanol, soluble in alcohol, and slightly soluble in chloroform and in acetone. Its chemical formula is C14H19NO2•HCl, and its molecular weight is 269.77.

Inactive Ingredients: Cetyl alcohol, ethylcellulose, anhydrous lactose and magnesium stearate.
The purpose of this study was to evaluate the preventive role and underlying mechanisms of fucoxanthin (Fx) on dextran sulfate sodium (DSS)-induced colitis in mice. The present data demonstrated that oral administration of Fx (50 and 200 mg/kg body weight/day) for 36 days significantly alleviated the severity of colitis in DSS-treated mice, as evidenced by attenuating body weight loss, bloody stool, diarrhea, shortened colon length, colonic epithelium distortion, a thin mucus layer, goblet cell depletion, damaged crypts, and extensive infiltration of inflammatory cells in the colonic mucosa. Additionally, Fx notably relieved DSS-induced intestinal epithelial barrier dysfunction via maintaining the tight junction function and preventing excessive apoptosis of colonic epithelial cells. Moreover, Fx effectively diminished colonic inflammation and oxidative stress in DSS-treated mice, and its mechanisms might be due to blunting the activation of NF-κB and NLRP3 inflammasome signaling pathways. Furthermore, Fx also modulates DSS-induced gut microbiota dysbiosis via recovering the richness and diversity of gut microbiota and reshaping the structure of gut microbiota, such as increasing the Firmicutes and Bacteroidota (F/B) ratio and elevating the relative abundance of some potential beneficial bacteria, including Lactobacillaceae and Lachnospiraceae. Overall, Fx might be developed as a promising functional ingredient to prevent colitis and maintain intestinal homeostasis.
The present invention provides a method for identifying inhibitors of protein kinases and/or protein phosphatases. Methods are also provided for inhibiting protein kinase and/or protein phosphatase activity. Specific non-peptide protein tyrosine kinase and/or protein phosphatase inhibitors are provided. The protein kinase or protein phosphatase inhibitors of the present invention may be used to treat a number of conditions in patients, including cancer, psoriasis, arthrosclerosis, immune system activity, diabetes, or obesity. In addition, the present invention provides a method for protecting against or treating hearing loss in a subject. This method involves administering an effective amount of a protein tyrosine kinase inhibitor to the subject to protect against or to treat hearing loss.
TMJ arthroscopy and Saline solution NaCl 0,9% in 2 syringes with 1 ml each. Injected in Right Masseter (0.5ml), Left Masseter (0.5ml), Right Temporalis (0.5ml) and Left Temporalis (0.5ml).
Formulations with preservative (see DESCRIPTION) contain benzyl alcohol, which is potentially toxic when administered locally to neural tissue.  Exposure to excessive amounts of benzyl alcohol has been associated with toxicity (hypotension, metabolic acidosis), particularly in neonates, and an increased incidence of kernicterus, particularly in small preterm infants. There have been rare reports of deaths, primarily in preterm infants, associated with exposure to excessive amounts of benzyl alcohol. The amount of benzyl alcohol from medications is usually considered negligible compared to that received in flush solutions containing benzyl alcohol. Administration of high dosages of medications containing this preservative must take into account the total amount of benzyl alcohol administered. The amount of benzyl alcohol at which toxicity may occur is not known. If the patient requires more than the recommended dosages or other medications containing this preservative, the practitioner must consider the daily metabolic load of benzyl alcohol from these combined sources (see PRECAUTIONS, Pediatric Use). 

Injection of SOLU-MEDROL may result in dermal and/or subdermal changes forming depressions in the skin at the injection site. In order to minimize the incidence of dermal and subdermal atrophy, care must be exercised not to exceed recommended doses in injections. Injection into the deltoid muscle should be avoided because of a high incidence of subcutaneous atrophy.

Rare instances of anaphylactoid reactions have occurred in patients receiving corticosteroid therapy (see ADVERSE REACTIONS). 

In patients receiving the 40 mg presentation of SOLU-MEDROL during the treatment for acute allergic conditions and where these symptoms worsen or any new allergic symptoms occur, consideration should be given to the potential for hypersensitivity reactions to cow's milk ingredients (see CONTRAINDICATIONS). If appropriate, administration of SOLU-MEDROL should be stopped, and the patient's condition should be treated accordingly. Alternative treatments, including the use of corticosteroid formulations that do not contain ingredients produced from cow's milk, should be considered for acute allergy management, where appropriate. 

Increased dosage of rapidly acting corticosteroids is indicated in patients on corticosteroid therapy who are subjected to any unusual stress before, during, and after the stressful situation.

Results from one multicenter, randomized, placebo-controlled study with methylprednisolone hemisuccinate, an intravenous corticosteroid, showed an increase in early (at 2 weeks) and late (at 6 months) mortality in patients with cranial trauma who were determined not to have other clear indications for corticosteroid treatment. High doses of systemic corticosteroids, including SOLU-MEDROL, should not be used for the treatment of traumatic brain injury.
The form of treatment will involve 16 weekly meetings of about 90 minutes each. Sessions involve both the child and parent and involve teaching youth how to cope with their anxiety through a variety of behavioral techniques.
Methods and compositions for therapy of pain are provided. Compositions comprising therapeutically effective amounts of two or more of an extract of  Ganoderma lucidum,  an extract of  Salvia miltiorrhiza  and an extract of  Scutellaria barbata  and optionally a therapeutically effective amount of an extract of  Hippophae rhamnoides  are provided. Novel synergistic effects of the use of these compounds in combination therapy are disclosed. Compositions exhibit multiple functions that are useful for the treatment of pain and inflammation. Compositions of the invention inhibit the activity of COX-2 to a greater extent than COX-1. Compositions of the invention also inhibit the nuclear accumulation of NF-kappaB and thus inhibit the expression of a number of proinflammatory molecules including COX-2.
Correctly formulated enterically coated nutrient pellets are able to significantly to lower the blood sugar level of type two diabetics when administered with a normal meal. The inventive composition is effective at dosage levels of 10 g or less. Effective doses of the composition contribute 42 kcal or fewer to the patient's diet. A preferred form of the composition contains lauric acid coated for release in the distal bowel. When taken with an ordinary meal, the effective dosage does not induce the ileal brake and is more than 50 times (often more than 100 times) as effective on per kilocalorie basis as an ordinary meal at eliciting increases in PYY and GLP-1. Thus, ordinary nutrients—as opposed to drugs—can be used to reduce blood sugar levels when administered at dosage levels that are not significant promoters of weight gain.
Participants aged 6 to 11 or 12 to 17 years received matching placebo linaclotide (LIN), 30 minutes before evening meal, once daily for 4 weeks. Administered as liquid oral solution for participants 6 to 11 years of age and solid oral capsule or liquid oral solution for participants 12 to 17 years of age.
Stretch hyperreflexia is often a target for treatment to improve gait in children with spastic cerebral palsy (CP). However, the presence of stretch hyperreflexia during gait remains debated. Therefore, we assessed the relation between gastrocnemius medialis muscle-tendon stretch and muscle activation during gait in children with CP compared to typically developing (TD) children. 3D gait analysis including electromyography (EMG) and dynamic ultrasound was carried out to assess, respectively gastrocnemius medialis activation and fascicle, belly, and tendon stretch during treadmill walking. Musculotendon-unit stretch was also estimated using OpenSim. Ratios of EMG/peak lengthening velocities and accelerations were compared between CP and TD. Velocity and acceleration peaks prior to EMG peaks were qualitatively assessed. EMG/velocity and EMG/acceleration ratios were up to 500% higher for CP (n = 14) than TD (n = 15) for most structures. Increased late swing muscle activation in CP was often preceded by fascicle and musculotendon-unit peak lengthening velocity, and early stance muscle activation by peaks in multiple structures. Increased muscle activation in CP is associated with muscle-tendon stretch during gait. Concluding, late swing muscle activation in CP appears velocity-dependent, whereas early stance activation can be velocity- and acceleration-dependent. These insights into stretch reflex mechanisms during gait can assist development of targeted interventions.
A track of major interest to prevent bleeding complications in ECCO2R, and more generally in extracorporeal circulations, is to prevent acquired Willebrand disease. Indeed, a loss of Willebrand factor high molecular weight multimers (Whmwm) is frequently observed in conditions characterized by a continuous blood flow, associated with a high incidence of bleeding. A publication suggested the existence of this phenomenon under ECCO2R achieved through the medical device Hemolung (Alung technology, USA). We preliminary observed an almost constant and early (\< 24 hours) decrease in Willebrand factor high molecular weight multimers under ECCO2R. Such a phenomenon is considered as a major factor of hemorrhagic complications. We hypothesize that use of pulsatile extracorporeal blood flow configuration during the full length of ECCO2R therapy, as authorized by the Xenios console (Xenios AG, Heilbronn), would preserve a normal value of Whmwm, mainly by changing the conditions of shear constraints ("shear stress").
Traditional family based weight control treatment program, without components from habituation theory incorporated into the treatment. Families meet weekly for 12 weeks, then by-weekly for 1 month and 1 monthly session for a total of 15 behavioral intervention sessions.
FIELD: medicine, vaccines. SUBSTANCE: invention represents vaccine conjugates, immunogenic polypeptides, nucleic acid molecules encoding immunogenic polypeptides, host-cells containing nucleic acid molecules encoding immunogenic polypeptides and methods for preparing vaccine conjugates and immunogenic polypeptides as well as nucleic acid molecules encoding immunogenic polypeptides. Except for, invention represents IgE-vaccine that induces response to "one's own" IgE in mammals. Invention provides reducing effects of IgE antibodies in mammal by decline of total and bound with receptor amount of IgE receptor in mammal. EFFECT: valuable properties of vaccine. 26 cl, 4 dwg, 10 ex
PURPOSE: The incidence of kidney stone disease has increased worldwide, resulting in high medical costs and social burden. Kidney stone disease shares some common features with the risk factors of cardiovascular diseases (CVDs). We investigated the association between cardiovascular health (CVH) based on the Life's Essential 8 (LE8) score developed by the American Heart Association and the incidence of kidney stone disease.
METHODS: We analyzed the data of 29,469 US adults aged 20 years or above from the National Health and Nutrition Examination Survey, 2007-2018. According to the LE8 score, CVH was divided into three categories: poor, intermediate, and ideal. Logistic regression was used to determine the association between CVH and the incidence of kidney stone disease by estimating odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: The average age of the participants was 48.6 years, and 50% of the participants were women. The numbers of participants with poor, intermediate, and ideal CVH were 4149, 19,782, and 5538, respectively. After adjusting for related confounding factors, ideal CVH was associated with a reduction in the odds of kidney stone occurrence as compared to poor CVH (adjusted OR [aOR]: 0.45, 95% CI: 0.35-0.57, p < 0.001). Moreover, if the ideal CVH metrics was ≥ 6, the odds of kidney stone occurrence decreased by up to 61% (aOR: 0.39, 95% CI: 0.30-0.51).
CONCLUSIONS: In the present study, ideal CVH, a factor indicative of a healthy lifestyle, was associated with lower odds of kidney stone occurrence.
Participants will attend 4 laboratory sessions that differ by cigarillo smoked: own brand and a then commercially available study cigarillo (Garcia y Vega game cigarillo) in tobacco flavor, concept flavor, and characterizing flavor. Consistent with our work and other's published work8-10, a baseline (BL) period will measure appeal to smoking one's usual brand cigarillo in their home environment for 7 days and then once in the laboratory (\>12-hour abstinence), at the end of the 7 days. Participants will then undergo 3 experimental conditions (counterbalanced, within-subjects): (1) 7 days smoking a concept flavored study cigarillo; (2) 7 days smoking a characterizing flavored study cigarillo; and (3) 7 days smoking a tobacco flavored study cigarillo. Participants will be instructed to switch their usual brand cigarillo for the assigned study cigarillo for each 7-day period. Other tobacco use will be allowed during that time without specific instruction to model real-world behavior. On the last day of each 7-day period of "take home" use, abstinent participants (\>12 hours) will smoke the assigned study cigarillo in the lab ad libitum, where subjective effects (e.g., satisfaction, craving reduction, psychological reward, throat hit), smoke exposure (CO boost), and behavior (e.g., number of puffs) will be assessed During each 7-day period of exposure, participants will complete assessments of cigarillo and other tobacco use and subjective effects to cigarillo use via once daily EMA.
Hallucinations are vivid and transient experiences of objects, such as images or sounds, that occur in the absence of a corresponding stimulus.1,2,3,4,5,6,7,8,9 To understand the neurocomputational mechanisms of hallucinations, cognitive neuroscience has focused on experiments that induce false alarms (FAs) in healthy participants,1,2,3,4,5,9 psychosis-prone individuals,1,3,4 and patients diagnosed with schizophrenia.5 FAs occur when participants make decisions about difficult-to-detect stimuli and indicate the presence of a signal that was, in fact, not presented. Since FAs are, at heart, reports, they must meet two criteria to serve as an experimental proxy for hallucinations: first, FAs should reflect perceptual states that are characterized by specific contents10,11,12 (criterion 1). Second, FAs should occur on a timescale compatible with the temporal dynamics of hallucinations13,14 (criterion 2). In this work, we combined a classification image approach15 with hidden Markov models16 to show that FAs can match the perceptual and temporal characteristics of hallucinations. We asked healthy human participants to discriminate visual stimuli from noise and found that FAs were more likely to occur during an internal mode of sensory processing, a minute-long state of the brain during which perception is strongly biased toward previous experiences17 (serial dependency). Our results suggest that hallucinations are driven by dynamic predictive templates that transform noise into transient, coherent, and meaningful perceptual experiences.
The present invention discloses a method for preparing a traditional Chinese medicine for treating nephritis. In the method of the present invention, traditional Chinese herbal medicines of musk, bezoar, cornu saigae tatariace powder, carbonized sanguisorba roots, dried alum, marmite, Chinese dates, etc. are used as raw materials which are mixed proportionally to prepare the traditional Chinese medicine. The traditional Chinese medicine is used for treating pyelonephritis, acute and chronic glomerulonephritis and nephrotic syndrome. The present invention solves the difficult problems that no special medicines exist clinically for trreating nephritis, and the nephritis does not cure for a long time and attacks repeatedly. The traditional Chinese medicine prepared by the method has the advantages of favorable clinical application effects (the effective rate reaches 100% and the cure rate is 90%.), no side effects and no recurrence after cure, and relieves the pain of patients.